Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma

Overview of attention for article published in Gene Therapy, December 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 13 patents

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 13 patents that reference this research output.

Methods and materials for treating cancer

Grant US-12697361-B2

United States of America

04 Aug 2026

Non-replicating virus-derived particles and uses thereof

Grant US-11110138-B2

United States of America

07 Sep 2021

Methods and materials for treating cancer

Grant US-10849964-B2

United States of America

01 Dec 2020

Non-replicating virus-derived particles and uses thereof

Application JP-2020014467-A

Japan

30 Jan 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 9 additional patents.